Aim: The COVID-pandemic has affected access to healthcare services worldwide, including the pediatric population. This systematic review and meta-analysis aimed to estimate the risk of severe diabetic ketoacidosis (DKA) among children with type 1 diabetes (T1DM) during the COVID-pandemic compared pre-pandemic era.

Methods: PubMed, EMBASE, and the Elsevier Coronavirus Research Repository Hub were searched for relevant observational studies. Studies published as an abstract or in non-English language were excluded. The primary outcome is the risk of severe DKA among children with T1DM during the COVID-pandemic compared to the prior-to-COVID-group. The second outcome is the risk of severe DKA among children with newly diagnosed T1DM. A random meta-analysis model was performed using R version 4.0.4 to estimate the relative risk of severe DKA.

Results: A total of 18 studies were included in this metanalysis. Severe DKA risk was 76% (RR 1.76, 95%CI 1.33-2.33, I2=44%) higher during the COVID-pandemic than the pre-COVID-period. Among patients with newly diagnosed T1DM, the risk of severe DKA was 44% higher for the during-COVID-group (RR 1.44, 95%CI 1.26-1.65; I2=64%) . The bias assessment of the included studies using the Newcastle-Ottawa Scale (NOS) showed that all studies had quality indicators (>7 points) . In addition, the results of Eager’s test did not show potential for publication bias.

Conclusions: This study showed that severe DKA risk had increased significantly during the COVID-pandemic compared to the pre-pandemic period.

Disclosure

O.Alfayez: None. J.Alfallaj: None. A.R.Almutairi: None.

© 2022 by the American Diabetes Association
2022
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.